NCT02538848View on ClinicalTrials.gov

Study of HTD4010 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

HTD4010

injectable solution

Trial Locations (1)

WA6009

Linear Clinical Research Limited, Perth

All Listed Sponsors
lead

HighTide Biopharma Pty Ltd

INDUSTRY

NCT02538848 - Study of HTD4010 in Healthy Volunteers | Biotech Hunter | Biotech Hunter